Figure 5.
Metabolomic analysis of metabolites altered upon CPI-613–radiation therapy (RT) combination treatment. MiaPaCa-2 cells were exposed to either CPI-613, 2 Gy RT, or their combination for 6 or 24 hours. Targeted metabolomics was then performed as described in Methods and Materials. Statistically significant and differentially expressed metabolites are presented (P < .05). (A, B) Venn diagram showing increased number of altered metabolites in the combination. (C, D) Heat maps showing top prioritized targets in 6 and 24 hours of treatment, respectively.